ANTHEM — Anthem BioSciences Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹425.48bn
- IN₹419.28bn
- IN₹18.45bn
Annual cashflow statement for Anthem BioSciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 3,651 | 5,461 | 4,973 | 4,773 | 6,569 |
| Depreciation | |||||
| Non-Cash Items | 154 | -91.6 | -365 | -370 | -165 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1,655 | -2,619 | -2,186 | -3,820 | -3,114 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 2,775 | 3,329 | 3,060 | 1,402 | 4,183 |
| Capital Expenditures | -1,158 | -1,576 | -1,889 | -2,963 | -3,145 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -803 | -479 | -1,871 | 749 | 1,624 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,961 | -2,055 | -3,760 | -2,215 | -1,521 |
| Financing Cash Flow Items | -110 | -23 | -256 | -357 | -97.9 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -633 | 1,807 | 640 | -772 | -1,336 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 182 | 3,081 | -60.6 | -1,585 | 1,326 |